SCHEMBL7306237

SCHEMBL7306237

CCOC(=O)ON1c2ccc(OC)cc2CCC1C(=O)OC

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 9/20 0.45
NOTUM Q6P988 1/20 0.42
MTNR1B P49286 7/20 0.41
NQO2 P16083 6/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
ACHE P22303 2/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MMP8 P22894 2/20 0.39
MMP3 P08254 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307135 0.90 MTNR1A (0.46) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL8742853 0.85 MTNR1A (0.47) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL8742926 0.85 MTNR1A (0.47) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL7316234 0.85 MTNR1A (0.47) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL8742789 0.77 MTNR1A (0.48) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL7305955 0.77 MTNR1A (0.48) MTNR1ANOTUMMTNR1BNQO2HSD17B10
SCHEMBL7336655 0.76 NOTUM (0.48) MTNR1ANOTUMMTNR1BHSD17B10ALDH1A1
SCHEMBL7343636 0.76 NOTUM (0.48) MTNR1ANOTUMMTNR1BHSD17B10ALDH1A1
SCHEMBL7338202 0.76 NOTUM (0.48) MTNR1ANOTUMMTNR1BHSD17B10ALDH1A1
SCHEMBL8742995 0.70 NOTUM (0.45) MTNR1ANOTUMMTNR1BHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699680-B1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SANOFI SYNTHELABO (FR) 2000-03-08 EP claimed